RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/31544253http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/31544253http://www.w3.org/2000/01/rdf-schema#comment"We aimed to analyse the relative abundance of miR-505 in age-related macular degeneration (AMD) and elucidate its underlying mechanisms. Relative expression of miR-505 was analysed by real-time polymerase chain reaction (PCR). Macrophage polarization was characterized by measurement of molecular markers including Ym-1, Arg-1, TNF-α and iNOS via both real-time PCR and Western blot. Vascular endothelial growth factor (VEGF) content was determined by enzyme-linked immunosorbent assay. Choroidal neovascularization (CNV) formation was evaluated by choroidal flat mount technique. The regulatory action of miR-505-5p on 3'UTR of Transmembrane Protein 229B (TMEM229B) was interrogated by luciferase reporter assay. miR-505 was aberrantly upregulated in both AMD and laser-induced choroidal neovascularization mouse model. Administration with miR-505 specific inhibitor suppressed M2 polarization in CNV mice as indicated by decreasing both Ym-1 and Arg-1. Meanwhile, VEGF expression and CNV formation were greatly suppressed by miR-505 inhibition as well. The similar phenotype was consolidated in Prostaglandin E2 (PGE2)-stimulated bone marrow-derived macrophages. At the molecular level, miR-505-5p directly targeted and negatively regulated TMEM229B expression, while forced ectopic expression of TMEM229B significantly rescued miR-505-imposed M2 polarization. Our data have uncovered the critical contribution of miR-505 in AMD, which is predominantly mediated by downregulation of TMEM229B."xsd:string
http://purl.uniprot.org/citations/31544253http://purl.org/dc/terms/identifier"doi:10.1111/sji.12832"xsd:string
http://purl.uniprot.org/citations/31544253http://purl.uniprot.org/core/author"Chen J."xsd:string
http://purl.uniprot.org/citations/31544253http://purl.uniprot.org/core/author"Liu Q."xsd:string
http://purl.uniprot.org/citations/31544253http://purl.uniprot.org/core/author"Lu L."xsd:string
http://purl.uniprot.org/citations/31544253http://purl.uniprot.org/core/author"Zhao S."xsd:string
http://purl.uniprot.org/citations/31544253http://purl.uniprot.org/core/author"Wang X."xsd:string
http://purl.uniprot.org/citations/31544253http://purl.uniprot.org/core/author"Yuan Q."xsd:string
http://purl.uniprot.org/citations/31544253http://purl.uniprot.org/core/author"Qiu S."xsd:string
http://purl.uniprot.org/citations/31544253http://purl.uniprot.org/core/date"2019"xsd:gYear
http://purl.uniprot.org/citations/31544253http://purl.uniprot.org/core/name"Scand J Immunol"xsd:string
http://purl.uniprot.org/citations/31544253http://purl.uniprot.org/core/pages"e12832"xsd:string
http://purl.uniprot.org/citations/31544253http://purl.uniprot.org/core/title"MiR-505 promotes M2 polarization in choroidal neovascularization model mice by targeting transmembrane protein 229B."xsd:string
http://purl.uniprot.org/citations/31544253http://purl.uniprot.org/core/volume"90"xsd:string
http://purl.uniprot.org/citations/31544253http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/31544253
http://purl.uniprot.org/citations/31544253http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/31544253
http://purl.uniprot.org/uniprot/Q8BFQ2#attribution-92E5AC58BDF16474F135EAD0A4D37EDAhttp://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/31544253
http://purl.uniprot.org/uniprot/#_G3UZR6-mappedCitation-31544253http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31544253
http://purl.uniprot.org/uniprot/#_G3UYL9-mappedCitation-31544253http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31544253
http://purl.uniprot.org/uniprot/#_P30557-mappedCitation-31544253http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31544253
http://purl.uniprot.org/uniprot/#_Q8BFQ2-mappedCitation-31544253http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31544253
http://purl.uniprot.org/uniprot/#_Q6PDF2-mappedCitation-31544253http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31544253
http://purl.uniprot.org/uniprot/P30557http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/31544253
http://purl.uniprot.org/uniprot/G3UZR6http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/31544253